GEODE CAPITAL MANAGEMENT, LLC - HOMOLOGY MEDICINES INC ownership

HOMOLOGY MEDICINES INC's ticker is FIXX and the CUSIP is 438083107. A total of 120 filers reported holding HOMOLOGY MEDICINES INC in Q3 2021. The put-call ratio across all filers is 0.53 and the average weighting 0.1%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of HOMOLOGY MEDICINES INC
ValueSharesWeighting
Q3 2023$378,540
+17.1%
323,459
-11.4%
0.00%
Q2 2023$323,201
-18.7%
365,199
-5.4%
0.00%
Q1 2023$397,591
+81708.8%
386,0110.0%0.00%
Q4 2022$486
-99.9%
386,011
-0.2%
0.00%
Q3 2022$622,000
-18.2%
386,857
+0.2%
0.00%
Q2 2022$760,000
-69.4%
385,927
-52.7%
0.00%
Q1 2022$2,482,000
-15.1%
816,594
+1.6%
0.00%
Q4 2021$2,924,000
-48.2%
803,399
+11.9%
0.00%
-100.0%
Q3 2021$5,650,000
+10.5%
717,997
+2.1%
0.00%0.0%
Q2 2021$5,113,000
-2.1%
703,377
+26.7%
0.00%0.0%
Q1 2021$5,223,000
-5.7%
555,123
+13.2%
0.00%0.0%
Q4 2020$5,537,000
+14.8%
490,503
+8.8%
0.00%0.0%
Q3 2020$4,822,000
-29.2%
450,741
+0.5%
0.00%0.0%
Q2 2020$6,814,000
+16.4%
448,638
+19.1%
0.00%
-50.0%
Q1 2020$5,852,000
-60.3%
376,628
-47.2%
0.00%0.0%
Q4 2019$14,756,000
+140.1%
712,930
+110.0%
0.00%
+100.0%
Q3 2019$6,145,000
-1.4%
339,540
+6.7%
0.00%
-50.0%
Q2 2019$6,230,000
+33.5%
318,363
+89.1%
0.00%
+100.0%
Q1 2019$4,668,000
-31.8%
168,368
-45.0%
0.00%0.0%
Q4 2018$6,842,000
+169.6%
306,066
+175.6%
0.00%0.0%
Q3 2018$2,538,000
+29.7%
111,061
+15.7%
0.00%0.0%
Q2 2018$1,957,00095,9800.00%
Other shareholders
HOMOLOGY MEDICINES INC shareholders Q3 2021
NameSharesValueWeighting ↓
5AM Venture Management, LLC 4,535,919$5,307,0251.53%
Western Standard LLC 250,060$292,5700.26%
OUP Management Co., LLC 64,000$74,8800.17%
Vivo Capital, LLC 370,068$432,9800.05%
Temasek Holdings (Private) Ltd 5,650,996$6,611,6650.04%
GEORGE KAISER FAMILY FOUNDATION 39,320$46,0040.01%
American Investment Services, Inc. 36,955$43,2380.01%
RBF Capital, LLC 58,700$68,6790.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 185,100$216,5670.01%
XTX Topco Ltd 21,188$24,7900.00%
View complete list of HOMOLOGY MEDICINES INC shareholders